Johnson Pharmacare Limited (BOM:532154)
India
· Delayed Price · Currency is INR 0.500
0.00 (0.00%)
At close: Mar 9, 2026
Johnson Pharmacare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 0.14 | 0.01 | 0.02 | 0.41 | 2.33 | Upgrade
|
| Cash & Short-Term Investments | 0.31 | 0.14 | 0.01 | 0.02 | 0.41 | 2.33 | Upgrade
|
| Cash Growth | 5083.33% | 921.43% | -22.22% | -95.57% | -82.55% | -16.56% | Upgrade
|
| Accounts Receivable | - | - | - | - | 10.5 | 16.8 | Upgrade
|
| Receivables | - | - | - | - | 10.5 | 53.67 | Upgrade
|
| Other Current Assets | - | 13.5 | - | - | - | - | Upgrade
|
| Total Current Assets | - | 13.64 | 0.01 | 0.02 | 10.91 | 55.99 | Upgrade
|
| Long-Term Investments | - | 422.92 | 455.58 | 455.58 | 541.79 | 522.59 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | -0 | - | Upgrade
|
| Total Assets | - | 579.26 | 598.3 | 598.3 | 599.81 | 594.84 | Upgrade
|
| Accounts Payable | - | - | - | - | - | 6.5 | Upgrade
|
| Other Current Liabilities | - | 11.51 | 11.26 | 9.76 | 11.35 | 0.01 | Upgrade
|
| Total Current Liabilities | - | 11.51 | 11.26 | 9.76 | 11.35 | 6.51 | Upgrade
|
| Long-Term Debt | - | 6.05 | 19.5 | 19.05 | 6.05 | 6.88 | Upgrade
|
| Other Long-Term Liabilities | - | 0 | - | - | - | - | Upgrade
|
| Total Liabilities | - | 17.57 | 30.77 | 28.81 | 17.4 | 13.4 | Upgrade
|
| Common Stock | - | 550 | 550 | 550 | 550 | 500 | Upgrade
|
| Additional Paid-In Capital | - | 44 | 44 | 44 | 44 | 94 | Upgrade
|
| Retained Earnings | - | -32.31 | -26.47 | -24.51 | -11.59 | -12.56 | Upgrade
|
| Shareholders' Equity | 561.12 | 561.69 | 567.53 | 569.49 | 582.41 | 581.44 | Upgrade
|
| Total Liabilities & Equity | - | 579.26 | 598.3 | 598.3 | 599.81 | 594.84 | Upgrade
|
| Total Debt | 11.05 | 6.05 | 19.5 | 19.05 | 6.05 | 6.88 | Upgrade
|
| Net Cash (Debt) | -10.74 | -5.91 | -19.49 | -19.04 | -5.65 | -4.56 | Upgrade
|
| Net Cash Per Share | - | -0.01 | -0.04 | -0.03 | -0.01 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | - | 550 | 550 | 550 | 550 | 550 | Upgrade
|
| Total Common Shares Outstanding | - | 550 | 550 | 550 | 550 | 550 | Upgrade
|
| Working Capital | - | 2.13 | -11.25 | -9.74 | -0.44 | 49.48 | Upgrade
|
| Book Value Per Share | - | 1.02 | 1.03 | 1.04 | 1.06 | 1.06 | Upgrade
|
| Tangible Book Value | 561.12 | 561.69 | 567.53 | 569.49 | 582.41 | 581.44 | Upgrade
|
| Tangible Book Value Per Share | - | 1.02 | 1.03 | 1.04 | 1.06 | 1.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.